Insulin pump outcomes are well understood for insulin-dependent individuals, such as those with type 1 diabetics, but initiation of pump therapy immediately following a diagnosis of insulin-dependent diabetes (such as post-pancreatectomy diabetes) is a novel approach. This evidence concerns the gene INS and diabetes mellitus.